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ABSTRACT
The risks of poor transition include delayed and
inappropriate transfer that can result in disengagement
with healthcare. Structured transition care can improve
control of chronic digestive diseases and long-term
health-related outcomes. These are the ﬁrst nationally
developed guidelines on the transition of adolescent and
young persons (AYP) with chronic digestive diseases from
paediatric to adult care. They were commissioned by the
Clinical Services and Standards Committee of the British
Society of Gastroenterology under the auspices of the
Adolescent and Young Persons (A&YP) Section.
Electronic searches for English-language articles were
performed with keywords relating to digestive system
diseases and transition to adult care in the Medline (via
Ovid), PsycInfo (via Ovid), Web of Science and CINAHL
databases for studies published from 1980 to September
2014. The quality of evidence and grading of
recommendations was appraised using the Grading of
Recommendations Assessment, Development and
Evaluation (GRADE) system. The limited number of
studies in gastroenterology and hepatology required the
addition of relevant studies from other chronic diseases
to be included.
These guidelines deal speciﬁcally with the transition
of AYP living with a diagnosis of chronic digestive
disease and/or liver disease from paediatric to adult
healthcare under the following headings;
1. Patient populations involved in AYP transition
2. Risks of failing transition or poor transition
3. Models of AYP transition
4. Patient and carer/parent perspective in AYP
transition
5. Surgical perspective
SUMMARY OF RECOMMENDATIONS
Recommendations: patient populations involved
in adolescent and young person transition
We recommend that adolescent and young person
(AYP) with IBD, coeliac disease and chronic liver
disease should be involved in formal transition
arrangements (Grading of Recommendations
Assessment, Development and Evaluation (GRADE)
recommendation: strong (C)).
Recommendations: risk of failing or poor AYP
transition
1. We recommend the use of structured transition
programmes to improve control of chronic
gastrointestinal (GI) disease in AYP (GRADE
recommendation: strong (C)).
2. We recommend the use of structured transition
programmes to enhance adherence to medica-
tions, clinic attendance and clinical outcomes
including organ survival in liver transplantation
(GRADE recommendation: strong (C)).
3. We suggest that the use of structured transition
programmes may increase disease related
knowledge in patients and carers/parents
(GRADE recommendation: weak (C)).
4. We suggest that a structured transition pro-
gramme may improve psychological outcome
and health-related quality of life in chronic GI
diseases (GRADE recommendation: weak (D)).
5. We suggest that the use of a structured transi-
tion programme may reduce adverse outcomes
such as hospitalisation, surgery and radiation
exposure in GI disease (GRADE recommenda-
tion: weak (C)).
Recommendations: models of AYP transition
1. We suggest that an overlap with both paediatric
and adult gastroenterology care is a core
element of every structured transition service
(GRADE recommendation: weak (C)).
2. We suggest that while there are numerous
models of transition there is no evidence to
support a particular type (GRADE recommen-
dation: weak (C)).
3. We recommend an effective transition model
may beneﬁt from inclusion of the following ele-
ments (GRADE recommendation: strong (D)):
A. Flexible timing of transition
B. A named transition coordinator to oversee
the process
C. Individualisation of the transition model
based on local expertise, stafﬁng, resources
and geography
D. Assessment of readiness for transfer
E. Disease-speciﬁc education programme
4. We recommend information technology as an
effective and cost-efﬁcient tool to facilitate tran-
sition (GRADE recommendation: strong (C)).
5. We recommend that AYP’s self-efﬁcacy is
enhanced by the use of virtual intervention and
electronic communication (GRADE recommen-
dation: strong (C)).
6. We recommend regular audit of the transition
service in order to improve the service,
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outcomes and assess key performance indicators (GRADE
recommendation: strong (D)).
Recommendations: patient and carer/parent perspective in
AYP transition
1. We suggest that healthcare professionals (HCPs) consider
concerns of AYP and their carers/parents during transition
and identify when additional emotional and psychological
support is required (GRADE recommendation: weak (D)).
2. We suggest that HCPs maintain the goal of empowering the
AYP to become independent while acknowledging the carer/
parent perspectives (GRADE recommendation: weak (C)).
3. We recommend that AYP identiﬁed as at risk of non-
adherence may beneﬁt from targeted speciﬁc educational
and organisational interventions (GRADE recommendation:
strong (C)).
4. We recommend that disease-speciﬁc information and educa-
tion be appropriate for the AYP developmental stage and
this should be reassessed over the period of transition
(GRADE recommendation: strong (C)).
5. We suggest the transition process addresses the AYP’s life-
style, future health concerns, educational/employment goals,
psychosocial health, sexuality and reproduction (GRADE
recommendation: weak (D)).
GUIDELINE DEVELOPMENT
Introduction
The requirement for the consensus guidelines on this topic was
highlighted by a national survey of physician and nurse attitudes
to transition conducted by the Adolescent and Young Persons
(AYP) Section of the British Society of Gastroenterology
(BSG).1 2 There is currently no European consensus guideline
available for clinicians working in this ﬁeld, although in 2015
the Italian Societies of Gastroenterology published a position
statement,3 as have the North America Society for Paediatric
Gastroenterology, Hepatology and Nutrition in 1993.4 The
guideline proposal was reviewed and accepted by the Clinical
Services and Standards Committee (CSSC) in 2014. Members
of the guideline committee were selected after an open invita-
tion for expressions of interest and divided into multidisciplin-
ary subgroups. The authors drafted a preliminary guideline
document following the ‘BSG Guideline Advice’ document.5 6
The draft guidelines were submitted for review by BSG AYP
Section, CSSC and BSG Council and revised in response to
their comments.
Data sources and search strategy
A systematic literature search was undertaken by a medical librar-
ian (RF) using four relevant databases, Medline (via Ovid),
Embase, Web of Science and CINAHL, aiming to capture all rele-
vant studies across disciplines including paediatric and adult
gastroenterology from 1980 to September 2014. MeSH search
terms relating to digestive system diseases (“gastrointestinal
disease”*, “hepatological disease”, “liver disease”, “digestives
system disease”), transition to adult care (“transition clinic”, “tran-
sition”* “transition process”, “transition care”, “transfer”), adoles-
cent (“adolescen”*, “young adult”* (were entered and combined,
and limited to ‘adolescent’ and ‘young adult’ (see online
supplementary appendix 1)). Following this, section working
groups reviewed all relevant articles and any additional records
identiﬁed through other sources in an iterative way, drawing on
clinical expertise in the ﬁeld to draw on key publications related to
AYP transition in non-GI or hepatology disorders.
*Denotes terms where truncation has been used.
Study eligibility and selection criteria
Members of the guideline group determined study eligibility for
inclusion in the ﬁnal consensus. Studies were initially screened
independently by all members of each subgroup. Decisions
regarding study inclusion were made by consensus within each
subgroup, with ﬁnal decisions regarding study inclusion made by
the relevant chair. Studies were included if (a) published in full
and (b) written in English. Studies were excluded if (a) they were
case studies or not empirical studies (eg, narrative reports) and (b)
they were only published in abstract. Additional studies of interest
were identiﬁed by hand searches of bibliographies and cited
references and by consultation with clinical experts in the ﬁeld.
Data extraction and quality assessment
Of 639 studies identiﬁed, a formal assessment of quality was
conducted using the GRADE system.7 8
Assessing the quality of the guidelines: the Agree II
instrument
The Agree II instrument is the recognised and accepted method
of assessing the quality of clinical guidelines.9 Six domains are
listed and the position of the current guideline in these domains
is stated:
1. Scope and purpose
The aim of the guideline is to provide clinical guidelines
based on current available literature for the care of AYP as they
progress from paediatric health services through to adult care,
for clinicians and other health professionals in gastroenterology
and hepatology.
2. Guideline development group membership and stakeholder
involvement
Membership of the guideline development group included
paediatric and adult gastroenterologists and hepatologists, spe-
cialist nurses and dieticians who were selected after an open call
for participation was published in the BSG newsletter. The
group also included patient and parent members as well as
representatives from appropriate patient organisations who were
invited to participate by the chairperson. The guideline develop-
ment group had three face-to-face meetings (30 September
2014, 20 January 2015 and 5 May 2015) where the scope and
remit of the guideline was planned and progress reviewed at key
stages. The guideline development group was divided into four
multidisciplinary subgroups; patient populations, risks of poor
transition, models of transition and, ﬁnally, the patient and
parent perspective (see online supplementary appendix 2). Each
subgroup had a nominated chairperson (RKR, DRG, SS and
PJS, respectively) with the responsibility of overseeing the
review of relevant literature and production of draft recommen-
dations and accompanying text for publication for that section
(see online supplementary appendix 2).
3. Rigour of development
The guideline development group met regularly for discussion
via face-to-face meetings and teleconferences during the period
from September 2014 to September 2015. The guidelines rely
on a formal assessment of study quality that was conducted
using the GRADE system.7 8 GRADE was used to determine (a)
quality of studies included into high (A), moderate (B), low (C)
or very low (D); and (b) assess guideline recommendations and
classify them as either STRONG or WEAK (tables 1 and 2). In
the guideline, we have stated the recommendations and the
associated GRADE of evidence together. Practice points were
included based on expert clinical experience and consensus of
opinion rather than these being supported by clinical research,
as used in European Crohn’s and Colitis Organisation (ECCO)
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and European Society for Paediatric Gastroenterology,
Hepatology and Nutrition (ESPAGHAN) guidelines.10 11
Face-to-face meetings were held to agree the recommenda-
tions. Areas of disagreement about the recommendation grade
were subject to discussion and, where necessary, voting by
members of the guidelines group with consensus achieved when
>80% were in agreement. Practice points were used where
formal recommendations were not possible due to a paucity of
appropriate research, but where the guideline development
group felt there was enough expert clinical experience and con-
sensus for these to be included. The guidelines were subject to
peer review by the CSSC and BSG Council for consideration of
publication in July 2016. This involved ﬁve expert reviewers
providing detailed feedback to the Guideline Development
Group. The review resulted in the writing committee (AJB, PJS,
JOL, SAM) undertaking changes and improvement in the
structure and content of the guideline that underwent subse-
quent approval by the Chair of the CSSC. The updated guide-
line was reviewed by all members of the Guideline Development
Group prior to submission for publication in September 2016.
4. Clarity and presentation
Recommendations are intended to be speciﬁc to particular
areas of transition and the process of transition in order to
provide clinicians and allied health professionals with guidance
to facilitate development of transition facilities with a local
setting and context.
5. Applicability
Within the guidance we have discussed organisational changes
that may be required to apply the recommendations and identiﬁed
areas suitable for monitoring, audit and service improvement.
6. Editorial independence and conﬂict of interest
Guideline group members have declared any conﬂicts of inter-
est, which are detailed at the end of the guideline.
PATIENT POPULATIONS INVOLVED IN AYP TRANSITION
Transition for GI disease areas
Until recently, there has been a lack of transition services for AYP
patients with chronic GI and liver diseases in the UK.1 12 13 The
most frequent GI areas where transition arrangements exist are
IBD followed by chronic liver disease comprising both trans-
planted and non-transplanted patients. A very small number of
patients with complex nutritional needs are transferred or transi-
tioned on an ad hoc basis although there are not dedicated clinics
for these patient groups in the UK. Until recently, the majority of
patients with coeliac disease and other common GI illnesses (con-
stipation, GORD), together with simple functional GI disorders,
have been transferred from paediatric to adult care or discharged
from paediatric care with the expectation that the primary care
physician will refer to an appropriate adult consultant if required.
However, after the initial evidence search for this guideline was
completed in 2016 the ﬁrst consensus guidelines regarding transi-
tion in coeliac disease recommend structured transition for this
patient group,14 and there has been recent interest in transition
Table 2 Guideline recommendations are classified as either strong
or weak by determining the balance of desirable and undesirable
outcomes using the GRADE system1
Rating the strength of a recommendation: balancing desirable and
undesirable outcomes
Strong recommendation Weak recommendation
Desirable outcomes +++ > undesirable
outcomes +
Desirable outcomes ++ >
undesirable outcomes +
Examples of desirable outcomes Examples of undesirable outcomes
▸ Increased longevity
▸ Reduction in morbid events
intervention designed to prevent
▸ Resolution of symptoms
▸ Improved quality of life
▸ Decreased resource use
▸ Decreased longevity
▸ Immediate serious
complications
▸ Short-term relatively minor side
effects
▸ Long-term rare serious adverse
events
▸ Impaired quality of life
▸ Inconvenience/hassle
▸ Increased resource use
Table 1 Individual studies included in the guideline are formally assessed using the GRADE system1 with the quality of the body evidence
rated, from ‘high’ (A) to ‘very low’ (D)
Modify the initial quality of a body of evidence
Study design
Initial quality of a body of
evidence Rate lower if Rate higher if
Quality of body
of evidence
Randomised controlled trials High★★★★ Risk of bias
−1 Serious
−2 Very
serious
Large effect
+1 Large
+2 Very large
High (A)★★★★
Inconsistency
−1 Serious
−2 Very
serious
Dose response
+1 Evidence of a gradient
Moderate
(B)★★★
Observational studies/qualitative
studies
Low★★ Indirectness
−1 Serious
−2 Very
serious
All plausible residual confounding
Imprecision
−1 Serious
−2 Very
serious
+1 would reduce a demonstrated effect Low (C)★★
Publication
bias
−1 Likely
−2 Very likely
+1 would suggest a spurious effect if no effect
observed
Very low (D) ★
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care for emerging diseases like eosinophilic oesophagitis15 and
complex functional GI disorders.
Prevalence of GI disease in this population
While published data exist on the prevalence of speciﬁc GI and
liver disease in AYPs, the actual numbers of patients who move
from paediatric to adult care with or without transition annually
have not been recorded systematically. This is important as it
will determine the potential impact of recommendations to
implement a transition service for a speciﬁc disease. An estimate
based on extrapolation from audits, surveys or expert opinion is
provided in table 3. Due to the comparatively larger sizes of the
patient populations—transition has to date been more fre-
quently undertaken in the IBD and liver disease patient popula-
tions, but is of increasing importance in other GI diseases such
as coeliac disease14 and in complex functional GI disorders.
However, the true requirement for transition care among AYP
with GI disease has still to be accurately deﬁned and data on the
number of transition clinics currently supporting AYPs through
the transition process are not available to be able to estimate
any shortfall in service provision. However, these ﬁgures are
likely to be underestimating the true prevalence of AYPs requir-
ing formal transition into adult services. The demand for spe-
cialist nutrition for paediatric GI and surgical disorders has
risen in recent years, suggesting that increasing numbers of AYP
patients may survive and require transition to adult services.
Furthermore, the number of complex enteral nutrition patients
will be signiﬁcantly higher than those requiring parenteral nutri-
tion support. Children with complex motility disorders will
make up a small proportion of these patients16 and therefore
may require formal transitioning into adult care with multidis-
ciplinary support given their symptomatology, nutrition support
and psychological comorbidity can be difﬁcult to manage.
Disease course and differences between AYP and adults
For speciﬁc GI diseases, there are documented variations in
prognosis and clinical course when the disease presents in child-
hood compared with adulthood. This has clear relevance for the
AYP transition process in these diseases. There are also clear dif-
ferences in diagnostic and therapeutic IBD management
dependent on age at diagnosis with a higher use of exclusive
enteral nutrition in children with Crohn’s disease and general
anaesthetic use for endoscopy in children compared with sed-
ation in adults. Furthermore, children presenting with IBD have
a more extensive disease phenotype and rapid early progression,
although there no clear differences reported in the rate of
disease complications.19
Although the clinical course of coeliac disease presenting in
childhood is often more severe than that presenting later in life,
it is difﬁcult to predict outcomes dependent on age at diagnosis
with sparse research in this area. There are no studies that assess
the beneﬁt or risk of good versus poor disease control during
the transition from paediatric to adult care. However, there are
differences in management as in children the diagnosis of
coeliac disease is often based on serology with supportive inves-
tigations without the need for duodenal biopsy, whereas histo-
logical evaluation is always recommended in adults.20 The use
of psychological management for functional GI illness in paedi-
atrics is higher than adult practice. Outside the GI tract, the
most common indication for liver transplant in children is for
congenital reasons (biliary atresia) compared with acquired liver
disease in adulthood.
Recommendations and practice points
We recommend that AYP with IBD, coeliac disease and chronic
liver disease should be involved in formal transition arrange-
ments (GRADE recommendation: strong (C)).
Practice points
▸ AYP with other chronic GI and liver conditions, including
complex functional disorders, are likely to beneﬁt from
formal transition arrangements and may be incorporated into
existing transition services.
▸ HCPs involved in the management of AYP should be aware
of the differences between classiﬁcation, diagnostic methods,
treatment and natural history of relevant paediatric and adult
chronic GI and liver diseases dealt with in transition clinics.
▸ Centres should audit their population of AYP with chronic
GI and liver diseases to determine the prevalence and service
requirements for transition.
Table 3 The estimated (and extrapolated) UK prevalence of chronic paediatric GI/liver conditions and number of patients transitioned each year
using the best available epidemiological, audit and survey data as well as expert opinion
GI/liver condition
UK paediatric prevalence (total population or
proportion within populations)
Estimated number of patients transitioned
per year
IBD* 7000 1000 (∼60% Crohn’s disease)
Chronic liver disease The prevalence of paediatric liver disease in
England between 2008 and 2014:
11–15 years: 1502
16–17: 624†17
Approximately 61–76 transplant cases per annum‡18
753 paediatric patients were transferred to adult services
between
2008 and 2014) (proportion which are non-transplant is
unknown)†17
Complex enteral No relevant data identified No relevant data identified
Parenteral nutrition (combination of long term in and
out of hospital)
290§ 60
Coeliac disease 3–13 per 1000 children, or approximately 1:80 to
1:300 children
600 per year
Allergic/eosinophilic oesophagitis Food allergy 0.6%4
Eosinophilic oesophagitis 0.2 per 100 000
No specific data
Functional GI disease ∼10%5 No specific data
*Estimates derived from the organisational IBD audit 2013 and local figures (RKR).
†Williams et al.17
‡Data from annual report on liver transplantation NHS England September 2014 (2004–2014).
§Data courtesy of Henry Gowens/Andy Barclay British Intestinal Failure Survey data (unpublished 2014).
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▸ HCPs involved in the management of AYP with chronic GI
and liver diseases should receive appropriate training in tran-
sition care such as the pitfalls and beneﬁts of transition and
strategies to improve transitional care.
▸ AYPs should be transitioned once they have ﬁnished or are in
the later stages of puberty. Patients with growth issues should
be transitioned once the growth issues are resolved.
RISK OF FAILING TRANSITION OR POOR TRANSITION
Transition to adulthood is a complicated process for most AYP
and is particularly so where AYP have chronic illnesses and
ongoing health needs. The transition process has increasingly
been recognised as covering a vulnerable period where unad-
dressed healthcare needs may have long-term consequences.21
Inadequate transition arrangements and adverse outcomes
Inadequate transition arrangements have been associated with a
number of adverse outcomes over a wide range of medical con-
ditions including diabetes,22 23 heart disease24 and haemato-
logical disorders.25 These consequences include delayed and
inappropriate care, poor communication with AYP and their
families, as well as emotional and often ﬁnancial stress for
patients, their families and healthcare systems. Following solid
organ transplantation, inadequate transition has been associated
with worsening adherence,26 increased graft loss27 and higher
mortality.26 There have been few speciﬁc studies in gastroenter-
ology and hepatology, but similar conclusions are emerging.
Inadequate transition in IBD is associated with clinic non-
attendance and non-adherence with medication, restricted
growth potential and an increased likelihood of requiring
surgery.28 In coeliac disease, inadequate transition arrangements
are associated with dietary non-adherence, anaemia and reduced
bone density.29
As the AYP grows into adulthood, considerations of further
education and employment become important. There is some
emerging data on the relevance of a coordinated transition
during adolescence in chronic disorders, which may have impact
on the future work and employment.30 31
Beneﬁts of successful transition in other chronic diseases
There is evidence to support the beneﬁts achieved by successful
transition programmes in chronic diseases in various disciplines.
For AYP with diabetes, successful transition has been shown to
result in improved objective measures of glycaemic control,
better engagement with screening programmes, improved out-
patient attendance and engagement with adult providers in add-
ition to decreased hospitalisation with diabetic ketoacidosis.32–35
In juvenile idiopathic arthritis and congenital heart disease,
successful transition was associated with improved self-
knowledge and improved disease knowledge among parents and
carers. These were accompanied by increased satisfaction with
the process and better quality of life.36 37 In renal diseases, an
integrated paediatric-adult clinical transition service was asso-
ciated with a striking reduction in the rate of graft loss among
the patients with renal transplants.38
Evidence to document the impact of successful transition in
gastroenterology and hepatology is more sparse. A recent UK
study in 72 patients (diagnosed with IBD in paediatric care and
then transferred to adult care service) who either went through
a formal transition programme versus no formal programme has
shown that establishment of a transition programme resulted in
improvements in drug adherence, clinical attendance and
growth with a reduced need for surgical intervention on retro-
spective analysis of their medical records.28 The same study also
showed a trend towards improved growth pattern in the transi-
tion patients. A French group that performed a retrospective
survey in 48 AYPs who had been transitioned from paediatric to
adult care showed that a structured transition programme results
in improved patients and carer satisfaction.39 Another study in
which 81 AYPs with a chronic illness (34 IBD, 13 cystic ﬁbrosis
and 34 type 1 diabetes mellitus) were randomised to either a
2-month web-based text delivered health educational pro-
gramme or a control group that received written materials
health-related topics to read has shown disease management,
health-related self-efﬁcacy (one’s belief in one’s ability to accom-
plish a speciﬁc health-related task) and patient-initiated commu-
nications were all improved by the use of a generic disease
management tool.40
Recommendations
We recommend the use of structured transition programmes to
improve control of chronic GI disease in AYP (GRADE recom-
mendation: strong (C)).
We suggest that the use of structured transition programmes
may increase disease related knowledge in patients and carers/
parents (GRADE recommendation: weak (C)).
We suggest that a structured transition programme may
improve psychological outcome and health-related quality of life
in chronic GI diseases (GRADE recommendation: weak (D)).
We suggest that the use of a structured transition programme
may reduce adverse outcomes such as hospitalisation, surgery
and radiation exposure in GI disease (GRADE recommendation:
weak (C)).
Improvements in adherence and compliance
Following liver transplantation non-adherence to immunosup-
pression is a major cause of graft loss and mortality.26 41
Non-adherence increases throughout adolescence and may
worsen when transfer is complete.26 The use of a dedicated
transplant coordinator results in better adherence and improved
self-management of healthcare needs. Thus, AYPs who had
moved from paediatric to adult care after liver transplant with
the support of a liver transplant coordinator had more appropri-
ate tacrolimus levels and enhanced healthcare management para-
meters compared with a historical comparison group.42
Medication adherence in IBD also appears to be increased fol-
lowing a structured transition programme.28
Recommendation
We recommend the use of structured transition programmes to
enhance adherence to medications, clinic attendance and clinical
outcomes including organ survival in liver transplantation
(GRADE recommendation: strong (C)).
MODELS OF AYP TRANSITION
The implementation of existing AYP transition models vary with
differences in approach and outcome dependent on coordin-
ation between the relevant HCPs. Various models have been
proposed and evaluated, but it remains unclear which transition
model is associated with the best outcomes for AYP.43
Combined care during transition
Surveys of different transition programmes in a variety of
medical disciplines have reported that combined clinic visits
with input from both paediatric and adult HCPs are clinically
beneﬁcial and endorsed by patients. However, the exact format
of transition may be highly variable and may include combined
Brooks AJ, et al. Gut 2017;0:1–13. doi:10.1136/gutjnl-2016-313000 5
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adult/paediatric clinics and/or joint multidisciplinary clinics or
‘virtual’ transition clinics.44
Recommendation
We suggest that an overlap between paediatric and adult gastro-
enterology care is a core element of every structured transition
service (GRADE recommendation: weak (C)).
Beneﬁt from AYP transition clinics in GI/liver diseases
Transition models incorporating a joint paediatric-adult clinic
that have been associated with improvements in clinically rele-
vant endpoints have been reported sparsely in gastroenterology
and hepatology but there is supporting evidence from other
chronic diseases that affect AYPs. For example in patients with
renal transplant, a transition model in which the use of a single
referral letter for transfer was replaced by an integrated
paediatric-adult clinical service was associated with a reduction
in the rate of graft loss.38 However, no signiﬁcant enhancement
of adherence, patient satisfaction or clinician’s subjective assess-
ment of graft stability was reported in another small study of
renal transplant recipients.45 In type 1 diabetes, signiﬁcant
improvements in HbA1c, rate of screening for complications of
the disease and attendance at clinic appointments have been
described in patients undergoing a structure transition planned
and coordinated with the adult team compared with those in
whom a letter of referral was used to transfer patients to the
adult services.32
In a single-centre study from the UK where the transition
clinic involved use of combined clinics with paediatric and adult
gastroenterology teams and using assessment of readiness to
transfer using tools, there were indicators for improvement in
clinically relevant outcomes such as adherence, surgery rates
and growth and development.15 In a further study from France,
the majority of patients attending a joint paediatric and adult
IBD clinic view a joint clinic as being beneﬁcial in transferring
information from their medical records and in building conﬁ-
dence in their new adult physician.39
Different transition models
The published guidance for speciﬁc models of transition lacks a
strong evidence base and originates from expert opinion as a
result of weak studies involving small patient numbers, bias and
multiple methodological ﬂaws within the data sets.32 44 46 47
However, a theoretical framework, entitled the Chronic Care
Model (CCM), describes how teams comprised of individuals
from different disciplines should approach the care of patients
with chronic health conditions.48 It identiﬁes the components
of care that are relevant to transfer. The CCM also identiﬁes the
major barriers to a successful transfer including a lack of coord-
ination between adult and paediatric services, a lack of planning
and resistance of patient and families to transition of their
healthcare. These themes were also identiﬁed in the UK survey
on transition care among paediatric and adult gastroenterolo-
gists involved in care of AYPs.1 A description of the application
of this model to a paediatric liver transplant population has
been published and illustrates how a theoretical framework can
be applied to implement organisational change.49
In a systematic review of practices that promote continuity
between child and adult services, recurring themes within the
literature were identiﬁed from which core principles of transi-
tion could be established. From this, four models of transition
were outlined (direct, sequential, developmental and profes-
sional).50 In the ‘direct’ model, the focus is primarily on rela-
tions between services and addresses continuity of information
between them, rather than focusing on the AYPs’ personal
growth and development. The ‘sequential’ model is more ﬂex-
ible and recognises that the AYPs’ needs are changing and that
they require some preparation if they are to adjust to adult care
successfully. A ‘developmental’ transitional model starts from the
premise that the AYP will need some help in acquiring the skills
and support systems necessary to use or experience adult care
effectively, with an active focus on personal growth and devel-
opment. Finally, in contrast to the other models, the ‘profes-
sional’ model focuses on the expertise from within one service
type (adult or paediatric) and not on the AYP. This may be
important in conditions with a short life expectancy or where
expertise is heavily located within one service, for example,
cystic ﬁbrosis, so is less applicable to chronic GI disease. These
models are not mutually exclusive with this guideline reﬂecting
aspects of all of these models in our recommendations but no
evidence to support a particular type exclusively.
Recommendation
We suggest that while there are numerous models of transition
there is no evidence to support a particular type (GRADE rec-
ommendation: weak (C)).
Essential components of AYP transition clinics
It is important to design the transition process to be ﬂexible and
dependent on patient factors including chronological age,
current disease activity, adherence with medical therapies, views
of AYP, view of the parents/carers and self-advocacy skills of the
patient. The crucial role of a named transition coordinator (eg,
for patients with IBD the paediatric IBD nurse who will remain
a constant contact and organise the transition process) is a recur-
ring theme in the literature and often scored as the key compo-
nent of the programme in many surveys.33 35 46 51 52
A systematic review of transition services between paediatric
and adult healthcare identiﬁed three core areas that require
attention when developing a successful transition service. These
comprised interventions aimed at stafﬁng requirements (transi-
tion coordinator) and service delivery (separate young adult
clinics, out-of-hours telephone support and enhanced follow-up)
and patients (educational programmes and skills training).33
AYP transition coordinator
The AYP transition coordinator is frequently a specialist nurse,
often, but not exclusively based within the paediatric
service.53 54 However, an expanded role of the transition coord-
inator has also been described and applied to patients who have
undergone liver transplantation.55 In this model, the transition
coordinator continues to work with the patients after transfer to
the adult services to help address gaps identiﬁed in the patients’
healthcare management.
Assessment of readiness to transfer
Several tools that assess the readiness to transfer have been
described some of which are disease-speciﬁc.56–61 The
Transition Readiness Assessment Questionnaire is a generic tool
that has a high internal consistency and validity.60 The
University of North Carolina TR(x)ANSITION Scale is a tool
for assessing the effectiveness of a transition process.57 It uses a
semistructured interview with the patient with use of the
medical records to verify data. It has a high inter-rater reliability.
These tools tend to focus on patients’ knowledge of disease and
skills. Psychometric data are not frequently collected. Data dem-
onstrating the ability of these tools to predict outcomes of tran-
sition are lacking.62 The involvement of parents who can
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overestimate AYP self-efﬁcacy63 and have higher levels of
anxiety than the AYP is deemed important.64
Disease-speciﬁc education programmes
A number of tools may be used to facilitate disease education
for transitioning patients. The ‘IBD passport’ (a wallet-sized
card containing personal and medical information about the
patient) has been identiﬁed as such a tool for transitioning AYPs
with IBD65 by identifying the areas of weakness in which AYPs
and parents require education and support such as awareness of
disease pathogenesis, disease location, characteristics, medica-
tions and health resources available to them. In a pilot study of
a disease-speciﬁc education programme in liver transplant recipi-
ents, a two-session education programme was associated with
improvements in adherence to immunosuppressant medications
and a reduction in elevated alanine aminotransferase (ALT)
levels.49 In the ﬁrst session, the focus was on educating the
patient and parents on their disease and the medication regi-
mens necessary to achieve disease control, while the second
session focused on practical aspects of taking responsibility for
one’s care in relation to taking medications, scheduling appoint-
ments, communicating directly to healthcare providers and
attending appointments alone.
The use of education programmes to facilitate the transition
process has been described in other chronic conditions.
Disease-speciﬁc education programmes and skills training have
been associated with improvement in HbA1c, acute complica-
tions, self-management skills and disease-speciﬁc knowledge in
patients with diabetes transitioning to the adult services.66
However, no improvement in quality-of-life scores was demon-
strated. In patients with juvenile idiopathic arthritis, an
age-adjusted structured transition programme that featured a
disease-speciﬁc programme of education was associated with an
improvement in disease-speciﬁc quality of life and continuous
improvements in knowledge of patients and their parents.36 No
impact was demonstrated on independent health behaviours.
Furthermore, disease education for HCPs is a vital component
of successful transition. A survey of adult and paediatric gastro-
enterologists in IBD identiﬁed suboptimal training in adolescent
care in 65% and 59% respectively as a barrier to successful
transition.1
Recommendation
We recommend an effective transition model (ﬁgure 1) may
beneﬁt from inclusion of the following elements (GRADE rec-
ommendation: strong (D)):
A. ﬂexible timing of transition
B. a named transition coordinator to oversee the process
C. individualisation of the transition model based on local
expertise, stafﬁng, resources and geography
D. assessment of readiness for transfer
E. disease-speciﬁc education programme.
We have suggested a transition pathway (ﬁgure 2) within this
guideline incorporating many of the recommendations and prac-
tice points into a practical overview.67
Use of technology in AYP transition programmes
Recent studies35 40 68 have highlighted the impact and interest
in web-based and mobile technologies to assist in the transition
process. Such technologies offer several unique advantages
including potential for individualisation of the health message
being delivered, anonymity, rapid access, low cost and ability to
overcome most geographical barriers. With wireless technologies
now being ubiquitous and text messaging being one of the main
forms of communication by adolescents today, we suggest that
such technology should be incorporated into the design of tran-
sition models to enable good, rapid communication with health
providers for reporting of symptoms, obtaining essential medi-
cations, ensuring appointments are not missed, as well as pro-
viding links to educational materials and useful websites and
support forums. In AYP with type I diabetes, the use of mobile
phone interventions have resulted in improved clinic attendance,
supported intensive insulin regimens and reduced progression
from ketosis to diabetic ketoacidosis in those with poor gly-
caemic control.69–71
A transition intervention for chronic disease (MD2Me) has
been tested in a number of chronic diseases including IBD.40
This intervention uses technology-based communication
between the healthcare team and patients (web-based and text
message-based intervention) to enhance access to the healthcare
team and to provide disease management and skills-based inter-
ventions. In a randomised controlled trial, this has been shown
to improve health-related self-efﬁcacy, performance of disease
management tasks and patient-initiated communications.
However, no beneﬁcial impact was demonstrated for
quality-of-life measure, functional performance or for disease
status.
Recommendations
We recommend information technology as an effective and cost-
efﬁcient tool to facilitate transition (GRADE recommendation:
strong (C)).
We recommend that AYP’s self-efﬁcacy is enhanced by the use
of virtual intervention and electronic communication (GRADE
recommendation: strong (C)).
Audit of transition programmes and research into their
impact
In view of the inability to recommend one speciﬁc transition
model for any speciﬁc service, we suggest regular clinical audit
of the transition process to identify weaknesses and facilitate
Figure 1 Diagrammatic illustration of the different components an
effective transition model should include.
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improvements in the process for the beneﬁt of HCPs, patients
and carers alike. This would beneﬁt from agreeing on key per-
formance indicators for transition generally that are then com-
plemented by disease-speciﬁc indicators. Audit should include
assessment of the number of eligible patients that access a
transition programme in addition to an assessment of the
impact of the programme and patient satisfaction. The impact
can be assessed using validated measures of disease-related
knowledge and tools that assess progress through the transition
process. Research into the impact of a successful transition
Figure 2 A transition pathway from paediatric to adult care for adolescent and young person (AYP) patients with chronic digestive disorders. MDT,
multidisciplinary team.
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programme is also required, which may include standard transi-
tion workshops that take place prior to and during the transi-
tion process.72 The rate of hospital admissions, use of support
services, attendance at outpatient clinic appointments, require-
ment for steroids, adherence to medications and patient satisfac-
tion would all be potential outcome measures for assessment of
the impact of a transition intervention.67 Qualitative studies that
assess the outcome of transition from a patient and parent per-
spective are also important. It is unlikely that a controlled trial
in this area will be performed due to methodological difﬁculties
in designing an appropriate trial as well as ethical concerns of
allocating a group of patients to ‘no transition’ when all expert
consensus suggests that this is inferior. Therefore, it is likely that
research will assess outcomes between centres that offer transi-
tion compared with those that do not. This will always suffer
from bias.
Recommendation
We recommend regular audit of the transition service in order
to improve the service, outcomes and assess key performance
indicators (GRADE recommendation: strong (D)).
PATIENT AND CARER/PARENT PERSPECTIVE IN AYP
TRANSITION
Addressing patient and carers/parents readiness during
transition
Anticipation of the timing of transition for AYPs has been identi-
ﬁed as one of the most important factors for its success.73 74
AYPs with non-GI chronic disease report frustration at inﬂexibil-
ity regarding a determined age of transfer.75 76 In a study of 28
AYPs with a variety of chronic conditions, AYPs did not identify
self-management as an indicator of readiness for transition and
some transition occurred before they were willing, or under-
stood the need.77 In patients with cystic ﬁbrosis up to
12 months post transition, AYPs felt that paediatric HCPs were
more concerned with the clinical parameters than the emotional
factors associated with transition, reporting feeling neglected in
this period while waiting for the move and being uncertain as to
who was responsible for their healthcare needs during this
period.78
Patient and carer/parents uncertainty and behaviour during
transition
AYPs with IBD may feel a sense of abandonment or be uncertain
regarding transfer to adult care79 while parents often feel a
sense of anxiety about joining a new healthcare team that may
not have been adequately informed about their condition.62 75 80
Furthermore, failure to connect with an adult healthcare pro-
vider post transition has been demonstrated to predict future
complications in diabetic patients.81
AYPs often face multiple transitions (education, employment)
at this stage in their lives, which may take priority over their
healthcare transition resulting in anxiety and uncertainty.78 In
this context, AYP may display regressive behaviour during transi-
tion82 and as a result transition services should identify this and
provide supporting emotional and psychological support. Age,
gender or severity of disease does not predict level of concern
about transition in cystic ﬁbrosis AYPs and their carers/
parents.64
The combination of difﬁcult symptoms and use of medica-
tions with signiﬁcant side effects such as corticosteroids results
in adolescents with IBD reporting poorer quality of life and an
increased prevalence of psychological distress and depres-
sion.83 84 The most common coping strategy employed by AYP
is ‘avoidant coping’; where an individual distracts himself or
herself with social diversion.85 This behaviour is associated with
disease relapse in adolescents.86 A number of studies show
improvement in adolescents overall psychological well-being
with psychological interventions indicating an important role
for the psychologist in IBD.87
Recommendation
We suggest that HCPs consider concerns of AYP and their
carers/parents during transition and identify when additional
emotional and psychological support is required (GRADE rec-
ommendation: weak (D)).
Empowering AYPs self-management: the role of the patient
and carers/parents
Carers/parents of AYP undergoing transition may ﬁnd it difﬁcult
to cope with their reduced role in medical care and should be
actively included where appropriate.78 88 Carer/parent protect-
iveness has been reported as a signiﬁcant challenge in transition
in patient with juvenile idiopathic arthritis.89 Furthermore,
HCPs may perceive AYPs ready to been seen independent of
their carers/parents at an earlier age than their carers/parents
do.90 Negotiating the appropriate level of protectiveness with
carer/parent should be based on the AYPS self-efﬁcacy and is an
important skill for HCPs to appreciate.50
Addressing motivational issues, teaching problem-solving
skills and addressing problematic patterns of family functioning
are more likely to beneﬁt individuals displaying intentional non-
adherence.91 92 AYPs displaying non-adherence may beneﬁt
from more frequent appointments, with intensiﬁed clinical
interventions.55
RECOMMENDATIONS
We suggest that HCPs maintain the goal of empowering the AYP
to become independent while acknowledging the carer/parent
perspectives (GRADE recommendation: weak (C).
We recommend that AYPs identiﬁed as at risk of non-adherence
may beneﬁt from targeted speciﬁc educational and organisational
interventions (GRADE recommendation: strong (C)).
Disease-speciﬁc information appropriate for developmental
age and gender
Disease-speciﬁc knowledge is an important part of AYP transi-
tion but information given is not always pertinent to AYPs stage
of development,89 93 with information more often geared
towards the carers/parents rather than AYPs.94 AYPs are taking
over self-management later than expected from carers/parents,95
with those >18 years often requiring signiﬁcant assistance from
carers/parents to book clinic appointments and order medica-
tions.96 Furthermore, the age of disease onset and timing of
medical interventions may play a role in mastery over healthcare
responsibilities. In liver transplantation, younger male recipients
struggled more with mastery over their healthcare compared
with those transplanted at an older aged and to females in any
age group.97
An organised transition programme should include age-
speciﬁc educational components to address the deﬁcits in AYP
knowledge.98 Acquisition of skills needed for successful transi-
tion should be a stepwise or age appropriate checklist for the
AYP.52 74 99 100 In IBD, a ‘transition protocol’ has been devel-
oped by Hait et al,74 which is based around developmental
milestones to anticipate the changes and normal expectations
for AYP for self-management and self-efﬁcacy whereby at differ-
ent ages (11–13, 14–16, 17–19 and 20–23 years old) a checklist
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of tasks for the medical team (eg, at 11–13 years old, HCP
introduces concept of future independent visits to the HCP)
and milestones for the AYP (eg, 14–16 years old, AYP knows
their own medical history) are gradually obtained on the proto-
col. However, this does not recognise the variable rate for
maturity and developmental milestones, with its inﬂexible
format being its major limitation.
RECOMMENDATION
We recommend that disease-speciﬁc information and education
be appropriate for the AYPs developmental stage and this
should be reassessed over the period of transition (GRADE rec-
ommendation: strong (C)).
Lifestyle, psychosocial health and sexuality
Studies in transplant recipients demonstrate that AYPs wish to
be treated as adults and prefer healthcare professionals to
address them instead of their parents. In addition, these studies
have identiﬁed that areas that may not be addressed in a paediat-
ric setting such as sexual relationships and recreational drug use
are important to AYPs, but they are often reluctant to ask for
such information.21 80 101
AYPs are often concerned that their illness will compromise
their employment and preclude them from valued jobs. In a
qualitative study of cystic ﬁbrosis and congenital heart disease,
AYPs and their carers/parents describe seeing the future as
uncertain, with particular concern regarding deteriorating
health and occupational restrictions in the future. Employment
issues are one of the primary sources of stress for cystic ﬁbrosis
AYPs in transition.102
AYPs with GI disease report major concerns regarding body
image and HCPs may encounter resistance to the use of corti-
costeroids in the transition period103 AYPs with IBD also
describe concerns relating to future fertility104 and a sense of
potential loss regarding normal gendered roles such as mother-
hood.102 Similarly AYPs with juvenile idiopathic arthritis express
concern over disclosing illness to sexual partners.89 105
Furthermore, AYPs’ liver transplant recipients express concern
about transmitting illness to descendants with concern regarding
immunosuppression on fertility and future children’s health and
demonstrating a lack of understanding of genetic risk.106
Furthermore, AYPs may not feel doctors understand the wider
impact on their life.89 105
Recommendation
We suggest the transition process addresses the AYP’s lifestyle,
future health concerns, educational/employment goals, psycho-
social health, sexuality and reproduction (GRADE recommenda-
tion: weak (D)).
SURGICAL PERSPECTIVE
There is limited data in relation to transition of AYP in the ﬁeld
of surgery. There are several groups of patients that may beneﬁt
from transition from paediatric to adult care:
1. Patients who have undergone surgery in a specialist paediat-
ric unit who require long-term follow-up and have reached
an age where care in a paediatric setting is no longer
inappropriate.
2. Patients who have been receiving ongoing paediatric medical
treatment for a condition requiring surgical intervention at
an age on the cusp of needing transition to an adult surgical
service.
3. Patients with newly diagnosed conditions needing surgical
intervention diagnosed at an age where transition to an adult
service is indicated.
While it would be possible for AYPs in the above groups to be
seen in a regular adult surgical outpatient setting, this would
require initiating a new dialogue with the adult surgeon. AYPs
and parents/carers may ﬁnd the adult clinic setting an intimidat-
ing experience compared with the more familiar paediatric
environment.
In a surgical gastroenterological transition clinic, the paediat-
ric surgeon can hand the case over to his adult surgeon col-
league. This may entail not only describing in detail the
procedures already performed by the paediatric surgeon but
also the nuances around any family dynamics and aspects of the
patients psyche. This will enable robust transfer of anatomical
surgical knowledge and engendering conﬁdence in the receiving
surgeon, AYP and parent/carers. In speciﬁc cases, it may also be
appropriate for the adult surgeon to consider operating jointly
with the paediatric surgeon if the AYP is not yet ready for
transition.
Practice point
▸ We suggest that AYPs who require surgical intervention during
the transition period have a named adult surgeon in the disci-
plined concerned involved in their care preoperatively, perio-
peratively and postoperatively, and that surgeon will form part
of the multidisciplinary team in transition care.
CONCLUSION
This guideline provides the framework for healthcare profes-
sionals to develop transition services for patients with chronic
GI disorders, using the best available research data from the lit-
erature related to AYPs with GI disorders and other chronic dis-
orders in which transition between paediatric and adult health
services is routinely done. The most signiﬁcant limitation of this
review is that the recommendations are predominantly based on
evidence graded as weak due to the paucity of randomised con-
trolled trials in this area. In addition, there is a signiﬁcant lack
of GI-speciﬁc data in this expanding ﬁeld and hence recommen-
dations are based on evidence not exclusively pertainable to
GI-speciﬁc research. Future studies are needed to improve the
strength of recommendations for future revisions of the guide-
lines. Furthermore, future research must consider design to
improve outcome-based data with longitudinal design in order
to aid future cost-beneﬁt analysis to be undertaken. Our hope is
that this guideline will stimulate more GI-related research in this
ﬁeld so future revisions will be supported by an expanding
robust and broad evidence base.
SCHEDULED REVIEW OF GUIDELINES
The proposed date for review is 1 August 2021 to take account
new developments in this area and as set out in the ‘BSG
Guideline Advice’ document.5 6 Every two years the research
objectives identiﬁed in the guidelines will be reviewed for evi-
dence of additional studies, which may contribute to resolving
the objectives. The guidelines are available on the BSG website
(http://www.bsg.org.uk) and listed by date of publication. These
guidelines are accessible to the public. There is a forum for feed-
back from BSG members via the forum link in the members’
area on the BSG website to ensure there is a facility for feedback
after publications. Any publication updates maybe published in
Gut as a letter subject to the normal review processes of the
journal and are submitted to the CSSC Secretary/Guidelines
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